3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
111
Neoplasms
100
Prostatic Neoplasms
53
Lung Neoplasms
53
Colorectal Neoplasms
50
Uterine Cervical Neoplasms
25
Motor Activity
25
Pancreatic Neoplasms
23
Ovarian Neoplasms
20
Brain Neoplasms
20
Head and Neck Neoplasms
17
Carcinoma, Hepatocellular
17
Glioblastoma
16
Stomach Neoplasms
14
Rectal Neoplasms
14
Colonic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Multiple Myeloma
12
Hematologic Neoplasms
12
Glioma
12
Leukemia
11
Disease
11
Depression
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Papillomavirus Infections
9
Melanoma
9
Anxiety Disorders
9
Carcinoma, Renal Cell
8
Sarcoma
7
Lymphoma, Follicular
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase NA
×
Infections
×
30 days
×
Clear all
NCT07209917
2026-06-04
SAKHI
University of California, Irvine
Phase NA
Recruiting
348 enrolled
NCT07296263
2026-06-04
Contrast PMR
Hyperfine
Phase NA
Enrolling by invitation
85 enrolled
NCT06829719
2026-05-27
TAOIST
Hospices Civils de Lyon
Phase NA
Recruiting
600 enrolled